237 related articles for article (PubMed ID: 34224408)
21. Combination of uric acid and NT-ProBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failure.
Park HS; Kim H; Sohn JH; Shin HW; Cho YK; Yoon HJ; Nam CW; Hur SH; Kim YN; Kim KB; Park HJ
Korean J Intern Med; 2010 Sep; 25(3):253-9. PubMed ID: 20830221
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of plasma renin activity in heart failure.
Vergaro G; Emdin M; Iervasi A; Zyw L; Gabutti A; Poletti R; Mammini C; Giannoni A; Fontana M; Passino C
Am J Cardiol; 2011 Jul; 108(2):246-51. PubMed ID: 21545993
[TBL] [Abstract][Full Text] [Related]
23. Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study.
Hao J; Cheang I; Zhang L; Wang K; Wang HM; Wu QY; Zhou YL; Zhou F; Xu DJ; Zhang HF; Yao WM; Li XL
Chin Med J (Engl); 2019 Oct; 132(19):2278-2285. PubMed ID: 31567379
[TBL] [Abstract][Full Text] [Related]
24. Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE).
Al-Zakwani I; Sulaiman K; Al-Lawati JA; Alsheikh-Ali AA; Panduranga P; Al-Habib KF; Al Suwaidi J; Al-Mahmeed W; Al-Faleh H; Elasfar A; Al-Motarreb A; Ridha M; Bulbanat B; Al-Jarallah M; Bazargani N; Asaad N; Amin H
Curr Vasc Pharmacol; 2018; 16(6):596-602. PubMed ID: 28820057
[TBL] [Abstract][Full Text] [Related]
25. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
JAMA; 2011 May; 305(20):2088-95. PubMed ID: 21610241
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
[TBL] [Abstract][Full Text] [Related]
27. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
28. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
29. The role of acute heart failure index (AHFI) combined with emergency heart failure mortality risk grade (EHMRG) in the evaluation of clinical outcomes and prognosis in patients with acute heart failure.
Wang Z; Dong Y; Gao Q; Zhang Q; Jiang H
Acta Cardiol; 2022 Aug; 77(6):488-493. PubMed ID: 34338593
[TBL] [Abstract][Full Text] [Related]
30. Low NT-proBNP levels: An early sign for the diagnosis of ischemic heart failure.
Zheng YR; Ye LF; Cen XJ; Lin JY; Fu JW; Wang LH
Int J Cardiol; 2017 Feb; 228():666-671. PubMed ID: 27883979
[TBL] [Abstract][Full Text] [Related]
31. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
32. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
[TBL] [Abstract][Full Text] [Related]
33. Association between cardiac, renal, and hepatic biomarkers and outcomes in patients with acute heart failure.
Chan WW; Waltman Johnson K; Friedman HS; Navaratnam P
Hosp Pract (1995); 2016 Aug; 44(3):138-45. PubMed ID: 27292609
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
Zile MR; Claggett BL; Prescott MF; McMurray JJ; Packer M; Rouleau JL; Swedberg K; Desai AS; Gong J; Shi VC; Solomon SD
J Am Coll Cardiol; 2016 Dec; 68(22):2425-2436. PubMed ID: 27908347
[TBL] [Abstract][Full Text] [Related]
35. NT-proBNP level in stage 3-4 chronic kidney disease and mortality in long-term follow-up: HAPPY study subgroup analysis.
Şimşek MA; Değertekin M; Türer Cabbar A; Hünük B; Aktürk S; Erdoğmuş S; Mutlu B; Kozan Ö
Turk Kardiyol Dern Ars; 2020 Jul; 48(5):454-460. PubMed ID: 32633264
[TBL] [Abstract][Full Text] [Related]
36. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
37. Predictors of Long-Term Mortality and Frequent Re-Hospitalization in Patients with Acute Decompensated Heart Failure and Kidney Dysfunction Treated with Renin-Angiotensin System Blockers.
Baydemir C; Ural D; Karaüzüm K; Balci S; Argan O; Karaüzüm I; Kozdağ G; Ağır AA
Med Sci Monit; 2017 Jul; 23():3335-3344. PubMed ID: 28690311
[TBL] [Abstract][Full Text] [Related]
38. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
[TBL] [Abstract][Full Text] [Related]
39. Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications.
Rey JR; Caro-Codón J; Rosillo SO; Iniesta ÁM; Castrejón-Castrejón S; Marco-Clement I; Martín-Polo L; Merino-Argos C; Rodríguez-Sotelo L; García-Veas JM; Martínez-Marín LA; Martínez-Cossiani M; Buño A; Gonzalez-Valle L; Herrero A; López-Sendón JL; Merino JL;
Eur J Heart Fail; 2020 Dec; 22(12):2205-2215. PubMed ID: 32833283
[TBL] [Abstract][Full Text] [Related]
40. PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial.
Huelsmann M; Neuhold S; Resl M; Strunk G; Brath H; Francesconi C; Adlbrecht C; Prager R; Luger A; Pacher R; Clodi M
J Am Coll Cardiol; 2013 Oct; 62(15):1365-72. PubMed ID: 23810874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
